Introduction-The Carotid Body and Hypoxia
=========================================

The mammalian carotid body (CB) is a highly specialized sensory organ derived from the neural crest. The sensory units of the CB are the 'glomus' or 'type I' cells that respond to a variety of stimuli including hypoxia, hypercapnia, acidosis and hormones thereby allowing the CB to function as a polymodal receptor ([@B37]; [@B53]; [@B61]). Type I cell activation leads to stimulation of adjacent chemoafferent fibers that relay sensory information into the central nervous system. The physiological consequence of CB stimulation is therefore the initiation of series of systemic protective reflexes characterized by increased ventilation, tachycardia, systemic vasoconstriction and adrenaline release from the adrenal medulla ([@B36]).

There is now a general consensus that a series of key processes contribute to the CB hypoxic chemotransduction cascade. These include attenuation of outward K^+^ current, type I cell depolarization, Ca^2+^ influx through L-type Ca^2+^ channels, neurosecretion and chemoafferent excitation ([@B39]; [@B41]). Single type I cells are exquisitely sensitive to O~2~ and rapid (within ms) activation of the hypoxic chemotransduction cascade initiates at PO~2~s of between 20--40 mmHg ([@B6]; [@B11]; [@B10]); a level considerably greater than that at which cell metabolism is affected in O~2~-insensitive cells.

What remains highly controversial is the molecular identity of the specific O~2~ sensor within the type I cell. We would argue that the physiological O~2~ sensor should exhibit certain key features: (1) expression in the type I cell permitting intrinsic O~2~ sensitivity; (2) the ability to bind O~2~; (3) its binding of O~2~ occurs over the physiological range at which the type I cell is stimulated; (4) it is required for the CB to be stimulated by hypoxia; and (5) it is able to activate the CB transduction cascade within milliseconds. Many proposed sensors fit one or two of these criteria but few have been shown to adequately comply with all five.

In mammalian cells, O~2~ is the terminal electron acceptor in the mitochondrial respiratory chain. Continuous binding and reduction of O~2~ in the CuB/haem a~3~ (cytochrome a~3~) binuclear center of complex IV drives mitochondrial electron transport and promotes activation of the mitochondrial ATP synthase. The long-established, mitochondrial hypothesis for chemoreception proposes that CB excitation induced by hypoxia is initiated by a reduction in O~2~ dependent mitochondrial energy respiration. This review will briefly critique the current evidence as to whether the mitochondria can be considered the functionally relevant O~2~ sensors within the CB.

Mitochondrial Inhibitors Mimic All Aspects of the Carotid Body Hypoxic Chemotransduction Cascade
================================================================================================

All mitochondrial poisons induce chemoafferent excitation ([@B35]; [@B46]; [@B48]; [@B17]; [@B26], [@B25]) leading to rapid increases in ventilation ([@B50]), heart rate and arterial blood glucose ([@B2]). Chemoafferent responses are rapid, dose dependent and reversible ([@B17]; [@B26]) and the magnitude of the rise in chemoafferent frequency caused by saturating concentrations is consistent with those evoked by severe hypoxia or anoxia ([@B35]; [@B46]; [@B48]). Furthermore, mitochondrial inhibitors and uncouplers augment neurotransmitter secretion, confirming an action through the type I cell rather than the afferent nerve endings ([@B48]; [@B54]). Despite the strong consistency between all of the different types of mitochondrial poisons (both in the older and more recent studies), it should be noted that some of the pharmacological agents used may not have acted selectively on the mitochondria and so the conclusions should be viewed with a certain degree of caution.

Mitochondrial poisons cause fast (within ms) type I cell depolarization and increases in \[Ca^2+^\]~i~. The size and timing of the \[Ca^2+^\]~i~ rise observed using many different mitochondrial inhibitors or uncouplers closely resembles that seen in hypoxia ([@B7]; [@B6]; [@B72]; [@B9]). As with hypoxia ([@B11]; [@B63]), the increases in \[Ca^2+^\]~i~ are dependent on cellular depolarization and extracellular Ca^2+^ influx through voltage gated Ca^2+^ channels ([@B72]). TASK1/3, TREK-1, BK~Ca~, K~v~4.1, and K~v~4.3, have all been shown to be expressed in the CB and inhibited by hypoxia ([@B12]; [@B55]; [@B69]; [@B75]; [@B29]; [@B34]; [@B62]; [@B67]). Of these, TASK1/3 and TASK-like K^+^ currents are diminished by a multitude of mitochondrial inhibitors leading to membrane depolarization ([@B3]; [@B72]; [@B9]; [@B62]; [@B31]).

Recent evidence has revealed the presence of TRP and other non-selective Ca^2+^-activated cation currents in type I cells that are activated by hypoxia ([@B38]; [@B28]; [@B32]; [@B66]). Although intriguing, the full functional relevance of these currents in type I cell O~2~-sensing remains to be further characterized, and in particular whether these currents can be upregulated to preserve O~2~ sensing in the absence of TASK channels ([@B62]). Current evidence suggests that mitochondrial inhibitors are also capable of increasing these inward depolarizing currents ([@B32]; [@B66]).

Mitochondria are Necessary for the Carotid Body to Respond to Hypoxia
=====================================================================

The presence of functional mitochondria does appear necessary for the CB to respond fully to hypoxia. For instance, cyanide, rotenone and FCCP all attenuate TASK channel currents in such a way that prevents any further reduction by hypoxia ([@B72]). In intact CB preparations oligomycin, cyanide and azide all reduce or abolish subsequent chemoafferent responses to hypoxia ([@B46]; [@B17]). Some of the attenuation observed in these experiments may have been due to impairment of oxidative phosphorylation in the chemoafferent fibers, limiting their excitability. Any such impairment is not apparent in response to physiological levels of hypoxia, since the PO~2~ that activates the type I cells occurs at a much higher level than those which would decrease mitochondrial function in the chemoafferent fibers. As such, chemoafferent responses to sustained hypoxia are better maintained than those in response to sustained high doses of mitochondrial inhibitors ([@B46]).

In a recent study the importance of mitochondrial complex I was tested by developing mice deficient in *Ndufs2* (a gene coding for NADH dehydrogenase \[ubiquinone\] iron-sulfur protein 2- a component of complex I that participates in ubiquinone binding) in tyrosine hydroxylase positive cells ([@B20]). Type I cells isolated from these mice were insensitive to hypoxia; they lacked any hypoxia-induced K^+^ current attenuation, \[Ca^2+^\]~i~ elevation or neurotransmitter release. Furthermore, these mice failed to increase respiratory frequency when breathing 10% O~2~. This work supported a previous study in which type I cell hypoxic chemosensitivity was abolished in the presence of rotenone ([@B49]). The authors propose a mechanism whereby exposure to hypoxia promotes reverse electron transport and ROS/NADH generation via complex I which is driven by a high rate of succinate oxidation at complex II. Accordingly, they have recently shown that genetic and pharmacological deactivation of complex II completely blocks type I cell hypoxic sensitivity ([@B21]).

This intriguing and elegant hypothesis does, however, show some discrepancies with evidence from earlier reports. For instance, similar experiments performed on CBs with heterozygous *Sdhd* knock out displayed an augmented, rather than depressed basal activity and had a completely preserved hypoxic response ([@B52]). Furthermore, when rat type I cells were exposed to tetramethyl-*p*-phenylenediamine (TMPD) and ascorbate in the presence of rotenone, there was still a robust elevation in Ca^2+^ upon hypoxic stimulation ([@B72]). This would suggest that feeding electrons into cytochrome c is sufficient to sustain type I cell hypoxic sensitivity even when complex I activity (and ROS generation) is inhibited. Complex IV activity rather than complex I and II may therefore be necessary for hypoxic chemotransduction. The same report also showed that application of H~2~O~2~ was unable to excite the type I cell directly. This observation is consistent with the lack of effect of multiple anti-oxidants used in other CB preparations and animal species ([@B56]; [@B1]; [@B23]). Interestingly, using novel *ex vivo* CB culture techniques combined with FRET based ROS sensors, [@B5] deduced that type I cell ROS actually decreases in hypoxia due to reduction in NADPH oxidase activity (an alternative ROS source). Clearly there is a need for reconciliation between these findings.

The Carotid Body Mitochondria are Unique and Have a Low Threshold for O~2~
==========================================================================

The evidence that mitochondria are required for CB O~2~ chemotransduction and that mitochondrial inhibitors can cause chemoexcitation, is not enough to define them as the O~2~-sensors in the CB. Clearly, mitochondria are able to bind O~2~. However, the K~m~ of the cytochrome a~3~ for O~2~ is reported to be \<1 mmHg in isolated mitochondria and between 1--5 mmHg in dissociated cells and tissue preparations, with little variation existing between different cell types ([@B71]; [@B59]). This is far lower than the PO~2~ at which the CB type I cells begin to be activated and, for this reason, is a common argument against the mitochondrial hypothesis.

However, there is now a substantial body of evidence indicating that the CB type I cell mitochondria are unique. Experiments performed by [@B44], [@B45]), were the first to identify an unusually low affinity cytochrome a~3~ within the CB. Using absorbance spectra, they estimated that 43--67.5% of total cytochrome a~3~ within the intact CB preparation had a remarkably low O~2~ affinity. This fraction was reported to be almost 100% reduced at PO~2~s between 7--9 mmHg and 50% reduced at a PO~2~ as high as 90 mmHg. In contrast, the remaining fraction was only 50% reduced at a PO~2~ of approximately 0.8 mmHg, comparable to cytochrome a~3~ found in other tissues ([@B22]). Thus, the CB appeared to express both low and high affinity subtypes of cytochrome a~3~. At that time, the specific cellular location(s) of each was unclear. Later experiments utilized the photolabile binding of CO, to deduce that saturation of cytochrome a~3~ with CO prevented any additional chemoafferent excitation during hypoxia, implying that not only was the cytochrome a~3~ in the CB unusual, it was also required for O~2~-sensing ([@B70]; [@B40]). It should be pointed out that the concentrations of CO used in these studies could have directly modified the activity of the BK~Ca~ channel ([@B69], [@B68]) and the generation of H~2~S ([@B76]) and as such some of the observations could be related to mechanisms independent of the mitochondria.

In dissociated rabbit type I cell clusters, mitochondrial electron transport begins to be inhibited at a high PO~2~ value of approximately 40 mmHg ([@B18]). PO~2~-NADH response curves demonstrate a significant 'right shift' in type I cells compared to sensory neurons, indicative of a heightened and distinctive O~2~ sensitivity. In addition, mitochondrial depolarization occurs at higher PO~2~s compared to O~2~-insensitive cells ([@B19]). More recent work has verified the "right shifts" in both PO~2~-NADH and PO~2~-rh-123 response curves in rat type I cells, confirming that the unusually low mitochondrial O~2~ affinity is conserved in multiple species ([@B62]). By isolating complex IV activity with a cocktail of mitochondrial inhibitors plus TMPD and ascorbate, the authors were able to reveal that complex IV activity is a component of the mitochondria with the exceptionally low O~2~ affinity. Importantly, type I cell hypoxic response curves for electron transport inhibition, mitochondrial depolarization and complex IV run-down display considerable overlap with the rise in Ca^2+^, indicating that these processes are intimately linked. Therefore, it does appear that type I cell mitochondria have a highly specialized *low affinity* for O~2~ due to an altered function/subtype of cytochrome a~3~ in complex IV that predisposes CB energy metabolism to being impaired at high O~2~ tensions. It is likely that the high affinity cytochrome a~3~ in the CB described by Mills & Jöbsis is located in the non-O~2~ sensing tissue such as the, nerve endings, blood vessels and type II cells.

Understanding the mechanism linking a fall in mitochondrial O~2~ consumption with K^+^ channel inhibition (or cation channel activation) is contentious. As previously mentioned, there could be a role for elevated mitochondrial ROS generation but this is still to be validated ([@B20]). Another possibility is an alteration in cytosolic nucleotides. Switching from a cell attached to inside-out patch configuration diminishes background K^+^ channel activity, suggesting that a basal level of an intracellular factor(s) activates TASK channels in normoxia ([@B65]). Addition of 5 mM MgATP in the inside-out configuration can restore about 50% of this background K^+^ channel activity. Both mitochondrial inhibition and hypoxia also significantly elevate free Mg^2+^, consistent with a decrease in MgATP. Thus, the fall in MgATP during hypoxia is likely to attenuate a significant proportion of TASK-current leading to depolarization. However, the remaining modulators that account for the other 50% of TASK current are still to be identified.

Another proposed mediator of TASK channel activity that is sensitive to changes in cytosolic nucleotide concentrations is AMPK ([@B73]). However, initial favorable studies based on pharmacological evidence have since been challenged by the finding that the AMPK-α~1~α~2~ deficient CB retains complete O~2~-sensitivity ([@B42]). Other groups have also shown that pharmacological targeting of AMPK does not impact on the hypoxia-induced K^+^ channel inhibition ([@B30]). Discrepancies may arise from the non-selectivity of the drugs used to evaluate AMPK function and potential redundancy mechanisms known to develop in genetic animal models ([@B47]). A final hypothesis is that a build-up in lactate upon mitochondrial inhibition in hypoxia activates the olfactory receptor Olfr78 ([@B15]). However, the concentration of lactate necessary to elevate Ca^2+^ in an intact CB preparation appears to be quite high (30 mM) and whether local levels reach this threshold during hypoxia is uncertain. We await a mechanism demonstrating how activation of Olfr78 (a G-protein-coupled receptor) modulates TASK or cation channel activity. A summary of the proposed O~2~-sensitive mitochondrial signaling pathways in the CB is presented in **Figure [1](#F1){ref-type="fig"}**.

![Carotid body mitochondrial signaling mechanisms activated during hypoxia. Hypoxia-induced mitochondrial inhibition is proposed to increase lactate generation ([@B15]), augment mitochondrial complex I reactive oxygen species (ROS) production ([@B20]) or reduce mitochondrial ATP synthesis ([@B10]). These changes are proposed to directly or indirectly (e.g., via Olf78 receptor activation, reduced MgATP concentration or stimulation of AMP-activated protein kinase; AMPK) modify ion channel function leading to resting membrane potential (RMP) depolarization. This causes opening of L-type Ca^2+^ channels, neurosecretion and an increase in discharge frequency of the adjacent chemoafferent fibers. TRP, transient receptor potential channel; NSC, non-selective cation channel; BK~Ca~, large conductance Ca^2+^-activated K^+^ channel; TASK, TWIK-related acid-sensitive K^+^ channel; TREK, TWIK-related K^+^ channel; AP, action potential.](fphys-09-00562-g001){#F1}

What Determines the Low O~2~ Affinity of the Carotid Body Mitochondria?
=======================================================================

We propose that there are 2 potential means to account for the extraordinary O~2~ sensitivity of type I cell mitochondria. First, there could be a high level of production of a cytosolic factor that is able to freely diffuse into the mitochondria and then compete with O~2~ binding in complex IV (**Figure [2](#F2){ref-type="fig"}**). We predict that this competition would render mitochondrial electron transport more susceptible to subsequent falls in O~2~. We recently tested this by applying exogenous nitrite to CBs and subsequently measuring hypoxic sensitivity ([@B26]). Nitrite is reduced within the mitochondria to generate local NO, a recognized competitive inhibitor of complex IV ([@B8]; [@B16]; [@B13], [@B14]; [@B4]). Moderate basal inhibition of the CB mitochondria by nitrite exaggerated the subsequent chemoafferent excitation during hypoxia signifying an increase in CB O~2~ sensitivity. Therefore, we validated the idea that CB hypoxic sensitivity could be adjusted by a factor capable of competing with O~2~ in the mitochondria and suggested a physiological role for endogenous NO in establishing type I cell mitochondrial O~2~-sensitivity. Measurable amounts of NO have been detected in mitochondrial of type I cells ([@B74]). A possible source is nitric oxide synthase 3 (NOS-3) given its location within the type I cell ([@B74]). Interestingly, mice with reduced NOS-3 have a dampened hypoxic ventilatory response and a depressed CB function ([@B33]). One explanation for this is an adaptation to chronic hypoxia brought about by reduced CB blood flow. However, this is unlikely as there is no significant type I cell hyperplasia/hypertrophy ([@B43]; [@B60]). Instead, the blunted CB activity could be due to the lack of NO acting on the CB mitochondria. Consideration of the precise compartmentalization of NO should also be taken into account. Whilst NO in the mitochondria induces chemostimulation, its action in other regions is likely to have opposing effects via modulation of soluble guanylate cyclase and L-type Ca^2+^/BK~Ca~ channels ([@B58]; [@B27]; [@B57]; [@B64]). In addition, other diffusible cytosolic factors have been implicated in CB O~2~ sensing including H~2~S and CO ([@B51]; [@B76]). Both of these gasses are capable of inhibiting type I cell mitochondria ([@B70]; [@B40]; [@B9]). Future experiments are required to evaluate if these substances act by setting type I cell mitochondrial O~2~ sensitivity.

![Potential mechanisms underlying the unique low O~2~ affinity mitochondria in the carotid body. Inhibition of mitochondrial function in the carotid body type I cell occurs at PO~2~ values well above those that inhibit metabolism in other O~2~ insensitive cells. This activates a number of proposed signaling pathways (shown in blue). The unique low O~2~ affinity of the carotid body mitochondria could be due to (1) a unique mitochondrial gene expression profile or (2) the presence of a competitive inhibitor such as NO ([@B26]). The impact of lower mitochondrial O~2~ affinity is to cause a right-shift in the PO~2~-chemoafferent response curve, thereby enhancing the functional O~2~ sensitivity and allowing the carotid body to respond over a more physiological range of arterial PO~2~s. RET, reverse electron transport.](fphys-09-00562-g002){#F2}

A second explanation for the low O~2~-affinity of the type I cell mitochondria is that it has a unique gene expression profile (**Figure [2](#F2){ref-type="fig"}**). Exploring gene expression in the CB is challenging due to its relatively small size and heterogeneity. However, advances in molecular biology techniques now make it possible to perform whole genome analysis using just micrograms of tissue or even single cells. RNA-sequencing analysis has now revealed a number of mitochondrial related genes that have a particularly high expression in the type I cell ([@B77]). Of these *Ndufa4l2* and *Cox4i2* have been shown to be more highly expressed in the CB compared with tissue from the superior cervical ganglion ([@B21]). Whether these two genes contribute to the low mitochondrial O~2~ affinity remains to be determined but these findings do support the idea that CB mitochondria have a unique genetic signature encoding their mitochondrial complexes. We would expect many more genetic studies to probe this further until the type I cell mitochondria can be accurately modeled to pinpoint the structural conformation underlying its low O~2~ affinity. An interesting comparator may be the mitochondria isolated from guinea pig CB which does not appear to have any inherent O~2~ sensitivity ([@B24]).

Conclusion
==========

On current evidence, it is very hard to disprove the mitochondrial hypothesis of CB O~2~ sensing. The mitochondria seem to fulfill all five criteria that we have proposed for adequate O~2~-sensors. What is less clear is a mechanistic understanding of how the low O~2~ sensitivity of the CB mitochondria is achieved and if mitochondria are involved in establishing pathological changes in CB function.
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